Cuprous Pharmaceuticals Inc.
Member Sector: Biopharmaceuticals
Cuprous Pharmaceuticals was incorporated in late 2016 and is a BC Cancer Agency start-up. We have a proprietary position enabling the development of metal-drug complexes: drug candidates that have activity in a wide range of diseases including cancer, drug resistant bacterial infections, inflammatory diseases and neurodegenerative diseases. Our goal is to partner with other biotechnology and pharmaceutical companies to develop this novel class of drugs. Using our proprietary Metaplex technology, Cuprous provides formulation solutions for the development of metal-based therapeutics as well as highly insoluble drug candidates that can interact with metal ions. The resultant metal complexes create the opportunity to generate new IP and extend the patent life of existing drugs.